You are here

  • Home
  • Archive
  • Volume 14, Issue Suppl 1
  • PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER

Article metrics

Article menu
Abstract
Posters October 5
PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER

 

Online download statistics by month:

Online download statistics by month:

No statistics are available.